| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/15/2004 | US20040135015 Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
| 07/15/2004 | US20040134412 Temperature activated systems |
| 07/15/2004 | US20040134091 Methods and apparatus for making particles using spray dryer and in-line jet mill |
| 07/15/2004 | US20040134010 Color changing matrix as wear indicator |
| 07/15/2004 | DE20320103U1 Composition for topical treatment of skin, useful for treating e.g. eczema and pruritus, comprises a fatty alcohol and three specific plant extracts |
| 07/15/2004 | DE202004005957U1 Chewable tablet for temporarily sealing the chewing surfaces of teeth to prevent caries comprises a sparingly water-soluble material |
| 07/15/2004 | DE10320604A1 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 07/15/2004 | DE10312259A1 Kosmetische oder dermopharmazeutische Zusammensetzung, umfassend ein Enzym, das in einem wässrigen Medium unlöslich ist, sowie deren Verwendung Cosmetic or dermopharmaceutical composition comprising an enzyme, which is insoluble in an aqueous medium, and the use thereof |
| 07/15/2004 | DE10261696A1 Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base The transdermal administration of rotigotine base |
| 07/15/2004 | DE10260873A1 Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin Self-adhesive polymer matrix having a content of seaweed extract and glycerin |
| 07/15/2004 | CA2533620A1 Dissolving film comprising a therapeutically active agent within the film or in a pouch formed by the film |
| 07/15/2004 | CA2512755A1 Water-soluble film for oral use |
| 07/15/2004 | CA2512199A1 Compositions of benzoquinolizine carboxylic acid antibiotic drug |
| 07/15/2004 | CA2512149A1 Film coated tablet comprising an extract of red vine leaves |
| 07/15/2004 | CA2511668A1 Polygonal barrel spattering device, polygonal barrel spattering method, coated particle formed by the device and method, microcapsule, and method of manufacturing the microcapsule |
| 07/15/2004 | CA2511217A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 07/15/2004 | CA2510779A1 Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate |
| 07/15/2004 | CA2510778A1 Methods for coating substrates for pharmaceutical uses with a mixture of two film-forming coating agents |
| 07/15/2004 | CA2510373A1 Compounds for oral dosage of active substances requiring a taste masking |
| 07/15/2004 | CA2510319A1 High pressure compaction for pharmaceutical formulations |
| 07/15/2004 | CA2510318A1 Improved nail drug delivery |
| 07/15/2004 | CA2510296A1 Steroid compositions for intraocular use |
| 07/15/2004 | CA2510292A1 Methods of treating non-painful bladder disorders using .alpha.2.delta. subunit calcium channel modulators |
| 07/15/2004 | CA2510196A1 Intracutaneous injection |
| 07/15/2004 | CA2509913A1 Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof |
| 07/15/2004 | CA2508592A1 High pressure spray-dry of bioactive materials |
| 07/15/2004 | CA2508225A1 Homogeneous solid granules containing carotenoids |
| 07/15/2004 | CA2507511A1 Ester combination local anesthetic |
| 07/15/2004 | CA2495124A1 Reversible masking of liposomal complexes for targeted delivery |
| 07/14/2004 | EP1437380A1 Polymeric hydrogel |
| 07/14/2004 | EP1437143A1 Injections for eye tissue containing drug bound to polyethylene glycol |
| 07/14/2004 | EP1437140A1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 07/14/2004 | EP1437136A1 Compositions comprising cannabinoids |
| 07/14/2004 | EP1437130A1 Percutaneous absorption preparations |
| 07/14/2004 | EP1437129A1 Gelatin-free shaped bodies encapsulating a liquid filling |
| 07/14/2004 | EP1437128A1 Pellet made from a matrix comprising tee as starting material and its method of preparation |
| 07/14/2004 | EP1437127A1 Suspension comprising oxcarbazepine |
| 07/14/2004 | EP1437126A1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 07/14/2004 | EP1437116A1 Multi-cored molded article, method of producing the same, and device for producing the same |
| 07/14/2004 | EP1436607A1 Ion-sensitive field effect transistor and a method for producing a transistor of this type |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436321A2 Synthesis of cyclosporin analogs |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436141A2 Systems, methods and apparatuses for manufacturing dosage forms |
| 07/14/2004 | EP1436057A2 Rotor-stator apparatus and process for the formation of particles |
| 07/14/2004 | EP1436018A1 Nitric oxide-releasing coated medical devices and method of preparing same |
| 07/14/2004 | EP1436010A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 07/14/2004 | EP1436009A1 Pharmaceutical formulation |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436007A2 Compounds for use as surfactants |
| 07/14/2004 | EP1436006A2 Viral inhibition by n-docosanol |
| 07/14/2004 | EP1435994A2 Novel use of pulmonary surfactant |
| 07/14/2004 | EP1435990A1 Kahalalide compounds for use in cancer therapy |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 07/14/2004 | EP1435971A1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 07/14/2004 | EP1435965A2 Pharmaceutical compositions and methods for treating cancer |
| 07/14/2004 | EP1435945A1 Transdermal migraine therapy |
| 07/14/2004 | EP1435931A2 Dosage form for treatment of diabetes mellitus |
| 07/14/2004 | EP1435929A1 Composition comprising cysteamine for improving lactation in dairy animals |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435923A2 Methods and apparatus for improved administration of analgesics |
| 07/14/2004 | EP1435922A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 07/14/2004 | EP1435921A1 Use of a multi-layer controlled-release tablet comprising ropinirole for the manufacture of medicament for the treatment of fibromyalgia |
| 07/14/2004 | EP1435920A1 Flow regulator |
| 07/14/2004 | EP1435919A2 Device and method for accurate delivery of an active agent |
| 07/14/2004 | EP1435918A1 Highly compressible ethylcellulose for tableting |
| 07/14/2004 | EP1435917A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 07/14/2004 | EP1435916A1 Powder processing with pressurized gaseous fluids |
| 07/14/2004 | EP1435915A1 Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 07/14/2004 | EP1435914A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides |
| 07/14/2004 | EP1435911A1 Devices including protein matrix materials and methods of making and using same |
| 07/14/2004 | EP1435910A1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/14/2004 | EP1435909A1 Stable composition comprising particles in a frozen aqueous matrix |
| 07/14/2004 | EP1435908A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 07/14/2004 | EP1435907A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 07/14/2004 | EP1435905A1 Binary composition for "prime-boost" release of active ingredients like vaccines |
| 07/14/2004 | EP1435874A1 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 07/14/2004 | EP1435801A1 Encapsulated materials |
| 07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/14/2004 | EP1435787A2 Nestin-expressing hair follicle stem cells |
| 07/14/2004 | EP1435786A1 Pesticidal formulations |
| 07/14/2004 | EP1435781A1 Solvent system |
| 07/14/2004 | EP1345979B1 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1202996B9 Titanium derived compounds, preparation and use thereof |
| 07/14/2004 | EP1171105B1 Transdermal therapeutic system with a highly effective neuroleptic agent |
| 07/14/2004 | EP1169026B1 Use of ap-1 activators to treat glaucoma and ocular hypertension |
| 07/14/2004 | EP1123104B1 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 07/14/2004 | EP1117736B1 Modified starch film compositions |
| 07/14/2004 | EP1045692B1 Skin protection composition |
| 07/14/2004 | EP0984774B1 Gastroretentive controlled release microspheres for improved drug delivery |
| 07/14/2004 | EP0971969B1 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same |
| 07/14/2004 | EP0954566B1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 07/14/2004 | EP0948358B1 Stable liquid interferon formulations |
| 07/14/2004 | EP0818989B1 Novel compositions of lipids and stabilizing materials |
| 07/14/2004 | EP0788348B1 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 07/14/2004 | CN2624893Y Alcohol-releasing health tablet with closet structure |